This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Tennessee Research Foundation. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Bernd Meibohm: Innovator in Anti-Tuberculosis Research
Introduction
Bernd Meibohm is a notable inventor based in Germantown, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tuberculosis agents. With a total of 2 patents, his work is recognized for its potential impact on treating infectious diseases.
Latest Patents
Meibohm's latest patents focus on novel compounds known as spectinamides. These compounds, specifically the 3'-deoxy-3'-acylaminospectinomycin, are described as effective agents against tuberculosis. The patents detail methods for utilizing these compounds and other spectinomycin analogs in treating tuberculosis and various microbial infections.
Career Highlights
Bernd Meibohm is affiliated with the University of Tennessee Research Foundation, where he conducts his research. His work has garnered attention for its innovative approach to combating tuberculosis, a disease that continues to pose a global health challenge.
Collaborations
Meibohm has collaborated with esteemed colleagues, including Richard Edward Lee and Jianjun Qi. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.
Conclusion
In summary, Bernd Meibohm is a dedicated inventor whose work in anti-tuberculosis research is paving the way for new treatments. His contributions to the field are invaluable and highlight the importance of innovation in addressing public health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile